Cargando…

Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease

The metalloproteinase family of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) was reported to be a novel locus associated with human coronary artery disease. This study aimed to investigate plasma ADAMTS-7 levels in stable obstructive CAD patients and elucidate the rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jie, Zhou, Boda, Yu, Haiyi, Han, Jiangli, Cui, Ming, Zhang, Fuchun, Wang, Guisong, Guo, Lijun, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134802/
https://www.ncbi.nlm.nih.gov/pubmed/27902619
http://dx.doi.org/10.1097/MD.0000000000005523
_version_ 1782471525309349888
author Yu, Jie
Zhou, Boda
Yu, Haiyi
Han, Jiangli
Cui, Ming
Zhang, Fuchun
Wang, Guisong
Guo, Lijun
Gao, Wei
author_facet Yu, Jie
Zhou, Boda
Yu, Haiyi
Han, Jiangli
Cui, Ming
Zhang, Fuchun
Wang, Guisong
Guo, Lijun
Gao, Wei
author_sort Yu, Jie
collection PubMed
description The metalloproteinase family of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) was reported to be a novel locus associated with human coronary artery disease. This study aimed to investigate plasma ADAMTS-7 levels in stable obstructive CAD patients and elucidate the relationship between plasma ADAMTS-7 levels and the severity of CAD assessed by the Syntax score. This was a single center cross-sectional study performed in 182 CAD patients. ELISA was used to measure plasma ADAMTS-7 levels. All patients were divided into subgroup according to the ADAMTS-7 median in this cohort: high group with ADAMTS-7 ≥0.99 ng/mL and low group with ADAMTS-7 <0.99 ng/mL. Furthermore, all patients were divided into tertiles according to their Syntax scores (low group: Syntax score ≤10.0; moderate group: 10.0 <Syntax score ≤18.0; high group: Syntax score >18.0). We followed up the participants continuously until the first major adverse cardiovascular event (MACE) for a mean time of 22.0 months. Plasma ADAMTS-7 levels in the high Syntax score group were significantly higher compared with the low Syntax score group (3.29 [0.08–26.3] ng/mL vs 1.24 [0.15–8.78] ng/mL, P = 0.010). Plasma ADAMTS-7 levels were significantly positively correlated with the Syntax score tertiles (r = 0.157, P = 0.035). Logistic regression analysis indicated that the plasma ADAMTS-7 level was one of the independent predictors for the Syntax score tertiles (B = 1.118, 95% CI: 1.194–7.830, P = 0.020), together with HbA1c (B = 0.946, 95% CI: 1.248–5.312, P = 0.010), uric acid (B = –0.019, 95% CI: 0.974–0.988, P<0.001), and coronary artery calcium score (B = –0.001, 95% CI: 0.998–0.999, P < 0.001). Compared with the low ADAMTS-7 group, the high ADAMTS-7 group had significantly higher Syntax score (17.10±8.42 vs 14.96 ± 8.11, P = 0.047). Kaplan–Meier analysis showed patients in the high plasma ADAMTS-7 group tend to have a lower event-free survival rate than patients in the low plasma ADAMTS-7 group, unfortunately, no difference was detected (86.8% vs 88.0%, log rank = 0.314, P = 0.575). The plasma ADAMTS-7 level was positively correlated with the Syntax score significantly. The elevated plasma ADAMTS-7 level may be involved in the severity of disease in patients with stable coronary artery disease.
format Online
Article
Text
id pubmed-5134802
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-51348022016-12-22 Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease Yu, Jie Zhou, Boda Yu, Haiyi Han, Jiangli Cui, Ming Zhang, Fuchun Wang, Guisong Guo, Lijun Gao, Wei Medicine (Baltimore) 3400 The metalloproteinase family of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) was reported to be a novel locus associated with human coronary artery disease. This study aimed to investigate plasma ADAMTS-7 levels in stable obstructive CAD patients and elucidate the relationship between plasma ADAMTS-7 levels and the severity of CAD assessed by the Syntax score. This was a single center cross-sectional study performed in 182 CAD patients. ELISA was used to measure plasma ADAMTS-7 levels. All patients were divided into subgroup according to the ADAMTS-7 median in this cohort: high group with ADAMTS-7 ≥0.99 ng/mL and low group with ADAMTS-7 <0.99 ng/mL. Furthermore, all patients were divided into tertiles according to their Syntax scores (low group: Syntax score ≤10.0; moderate group: 10.0 <Syntax score ≤18.0; high group: Syntax score >18.0). We followed up the participants continuously until the first major adverse cardiovascular event (MACE) for a mean time of 22.0 months. Plasma ADAMTS-7 levels in the high Syntax score group were significantly higher compared with the low Syntax score group (3.29 [0.08–26.3] ng/mL vs 1.24 [0.15–8.78] ng/mL, P = 0.010). Plasma ADAMTS-7 levels were significantly positively correlated with the Syntax score tertiles (r = 0.157, P = 0.035). Logistic regression analysis indicated that the plasma ADAMTS-7 level was one of the independent predictors for the Syntax score tertiles (B = 1.118, 95% CI: 1.194–7.830, P = 0.020), together with HbA1c (B = 0.946, 95% CI: 1.248–5.312, P = 0.010), uric acid (B = –0.019, 95% CI: 0.974–0.988, P<0.001), and coronary artery calcium score (B = –0.001, 95% CI: 0.998–0.999, P < 0.001). Compared with the low ADAMTS-7 group, the high ADAMTS-7 group had significantly higher Syntax score (17.10±8.42 vs 14.96 ± 8.11, P = 0.047). Kaplan–Meier analysis showed patients in the high plasma ADAMTS-7 group tend to have a lower event-free survival rate than patients in the low plasma ADAMTS-7 group, unfortunately, no difference was detected (86.8% vs 88.0%, log rank = 0.314, P = 0.575). The plasma ADAMTS-7 level was positively correlated with the Syntax score significantly. The elevated plasma ADAMTS-7 level may be involved in the severity of disease in patients with stable coronary artery disease. Wolters Kluwer Health 2016-12-02 /pmc/articles/PMC5134802/ /pubmed/27902619 http://dx.doi.org/10.1097/MD.0000000000005523 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 3400
Yu, Jie
Zhou, Boda
Yu, Haiyi
Han, Jiangli
Cui, Ming
Zhang, Fuchun
Wang, Guisong
Guo, Lijun
Gao, Wei
Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
title Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
title_full Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
title_fullStr Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
title_full_unstemmed Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
title_short Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
title_sort association between plasma adamts-7 levels and severity of disease in patients with stable obstructive coronary artery disease
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134802/
https://www.ncbi.nlm.nih.gov/pubmed/27902619
http://dx.doi.org/10.1097/MD.0000000000005523
work_keys_str_mv AT yujie associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT zhouboda associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT yuhaiyi associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT hanjiangli associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT cuiming associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT zhangfuchun associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT wangguisong associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT guolijun associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease
AT gaowei associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease